Neurogenic overactive bladder in spinal cord injury and multiple sclerosis: role of onabotulinumtoxinA

被引：6

作者：

Ethans, K. D. ^{[1
,2
]}

Casey, A. R. ^{[1
,2
]}

Bard, R. J. ^{[1
,3
]}

Namaka, M. P. ^{[1
]}

机构：

[1] Univ Manitoba, RR143A-800 Sherbrook St, Winnipeg, MB R3P0C1, Canada

[2] Hlth Sci Ctr, Sect Phys Med & Rehabil, Winnipeg, MB, Canada

[3] Hlth Sci Ctr, Urol Sect, Winnipeg, MB, Canada

来源：

DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE | 2014年 / 4卷

关键词：

neurogenic detrusor overactivity; overactive bladder; onabotulinumtoxinA; multiple sclerosis; spinal cord injury;

D O I：

10.2147/DNND.S40349

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

People with neurogenic overactive bladder from either multiple sclerosis or spinal cord injury often suffer significant morbidity and decreased quality of life. Here we review the pathophysiology of neurogenic overactive bladder and the impact it can have on people with multiple sclerosis or spinal cord injury. We also address the various traditional treatment options and focus on the use of botulinum toxin A (specifically onabotulinumtoxinA) for this condition.

引用

页码：65 / 73

页数：9

共 42 条

[1] Botulinum Toxin-A Injections Into Neurogenic Overactive Bladder-To Include or Exclude the Trigone? A Prospective, Randomized, Controlled Trial [J].

Abdel-Meguid, Taha A. .

JOURNAL OF UROLOGY, 2010, 184 (06) :2423-2428

[2]

Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052

[3] Targeting recovery: Priorities of the spinal cord-injured population [J].

Anderson, KD .

JOURNAL OF NEUROTRAUMA, 2004, 21 (10) :1371-1383

[4] Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity [J].

Apostolidis, A ;

Popat, R ;

Yiangou, Y ;

Cockayne, D ;

Ford, APDW ;

Davis, JB ;

Dasgupta, P ;

Fowler, CJ ;

Anand, P .

JOURNAL OF UROLOGY, 2005, 174 (03) :977-982

[5] Health problems of persons with spinal cord injury living in the Netherlands [J].

Bloemen-Vrencken, JHA ;

Post, MWM ;

Hendriks, JMS ;

De Reus, ECE ;

De Witte, LP .

DISABILITY AND REHABILITATION, 2005, 27 (22) :1381-1389

[6] P2X3-immunoreactive nerve fibres in neurogenic detrusor overactivity and the effect of intravesical resiniferatoxin [J].

Brady, CM ;

Apostolidis, A ;

Yiangou, Y ;

Baecker, PA ;

Ford, AP ;

Freeman, A ;

Jacques, TS ;

Fowler, CJ ;

Anand, P .

EUROPEAN UROLOGY, 2004, 46 (02) :247-253

[7] OnabotulinumtoxinA improves quality of life in patients with neurogenic detrusor overactivity [J].

Chancellor, Michael B. ;

Patel, Vaishali ;

Leng, Wendy W. ;

Shenot, Patrick J. ;

Lam, Wayne ;

Globe, Denise R. ;

Loeb, Alex L. ;

Chapple, Christopher R. .

NEUROLOGY, 2013, 81 (09) :841-848

[8] Randomized Double-blind, Active-controlled Phase 3 Study to Assess 12-Month Safety and Efficacy of Mirabegron, a β3-Adrenoceptor Agonist, in Overactive Bladder [J].

Chapple, Christopher R. ;

Kaplan, Steven A. ;

Mitcheson, David ;

Klecka, Jiri ;

Cummings, Jana ;

Drogendijk, Ted ;

Dorrepaal, Caroline ;

Martin, Nancy .

EUROPEAN UROLOGY, 2013, 63 (02) :296-305

[9] Efficacy and Safety of OnabotulinumtoxinA in Patients with Urinary Incontinence Due to Neurogenic Detrusor Overactivity: A Randomised, Double-Blind, Placebo-Controlled Trial [J].

Cruz, Francisco ;

Herschorn, Sender ;

Aliotta, Philip ;

Brin, Mitchell ;

Thompson, Catherine ;

Lam, Wayne ;

Daniell, Grace ;

Heesakkers, John ;

Haag-Molkenteller, Cornelia .

EUROPEAN UROLOGY, 2011, 60 (04) :742-750

[10]

DEGROAT WC, 1990, NEUROBIOLOGY INCONTI

← 1 2 3 4 5 →